SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0

Historical Holders from Q1 2019 to Q2 2023

Type / Class
Debt / NOTE 0.625% 4/0
All holders as of 30 Jun 2023
Q2 2023
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0

Period Principal Value Change Price Investors
2023 Q2 0 $0 -$392,925,321 0
2023 Q1 393,849,741 $393,941,137 -$21,694,890 $0.9999 40
2022 Q4 415,075,000 $408,576,605 +$10,082,645 $0.9825 45
2022 Q3 398,553,065 $388,951,616 +$1,216,858 $0.9748 39
2022 Q2 397,707,000 $386,667,091 -$9,656,247 $0.9707 39
2022 Q1 407,409,784 $400,891,752 +$4,666,827 $0.9829 41
2021 Q4 402,317,675 $398,332,341 +$12,044,634 $0.9918 39
2021 Q3 388,952,675 $383,102,487 -$11,850,144 $0.9857 41
2021 Q2 390,734,324 $385,595,690 +$5,416,627 $0.9879 43
2021 Q1 385,799,649 $373,205,179 -$18,484,401 $0.9667 44
2020 Q4 405,389,800 $386,922,438 +$50,585,288 $0.9484 44
2020 Q3 352,061,084 $324,909,891 +$43,301,590 $0.9223 41
2020 Q2 305,602,088 $270,133,532 -$1,308,641 $0.8848 41
2020 Q1 316,716,637 $256,209,800 -$13,969,327 $0.8037 42
2019 Q4 324,677,440 $294,978,957 -$55,240,585 $0.9082 42
2019 Q3 353,229,426 $328,455,222 -$20,999,650 $0.9293 31
2019 Q2 373,094,912 $366,446,586 +$199,449,681 $0.976 35
2019 Q1 171,088,000 $165,522,000 +$165,522,000 $0.9684 9